Nanosonics Jumps on Earnings Beat, In-Line Guidance -- Market Talk

Dow Jones
2025/08/26

0036 GMT - Nanosonics rises 11% to A$4.57 following its annual result, with RBC Capital Markets calling it a relief rally as shares in the medical-device maker had been weak for a while. Nanosonics reported an underlying net profit of A$20.7 million in FY 2025, above RBC's A$17.7 million forecast. It also provided maiden revenue guidance of A$215 million-A$223 million for FY 2026, implying 8-12% growth, along with other forecasts. "Management's guidance includes A$4 million of tariff impact, although there are some mitigation strategies expected to offset the majority of tariff impact at the pretax profit level," says analyst Craig Wong-Pan. Nanosonics is on course for its best close since mid-May. (david.winning@wsj.com; @dwinningWSJ)

 

(END) Dow Jones Newswires

August 25, 2025 20:36 ET (00:36 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10